No more typing reviews! Try our Samantha, our new voice AI agent.

AWS X-Ray vs ITRS Geneos comparison

Why PeerSpot?
 

Comparison Buyer's Guide

Executive SummaryUpdated on Jul 24, 2024

Review summaries and opinions

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Categories and Ranking

AWS X-Ray
Ranking in Application Performance Monitoring (APM) and Observability
27th
Average Rating
7.8
Reviews Sentiment
6.6
Number of Reviews
11
Ranking in other categories
No ranking in other categories
ITRS Geneos
Ranking in Application Performance Monitoring (APM) and Observability
33rd
Average Rating
8.2
Reviews Sentiment
7.0
Number of Reviews
58
Ranking in other categories
Network Monitoring Software (37th), IT Infrastructure Monitoring (28th)
 

Mindshare comparison

As of October 2026, in the Application Performance Monitoring (APM) and Observability category, the mindshare of AWS X-Ray is 1.0%, down from 2.7% compared to the previous year. The mindshare of ITRS Geneos is 0.9%, down from 1.1% compared to the previous year. It is calculated based on PeerSpot user engagement data.
Application Performance Monitoring (APM) and Observability Mindshare Distribution
ProductMindshare (%)
AWS X-Ray1.0%
ITRS Geneos0.9%
Other98.1%
Application Performance Monitoring (APM) and Observability
 

Featured Reviews

Muhmad Tabrez A Deewanji - PeerSpot reviewer
Lead Software Engineer at a tech services company with 1,001-5,000 employees
Improving performance through efficient trace metrics and data insights
As an application developer and architect, I appreciate AWS X-Ray for checking latency and identifying bottlenecks. I use it for performance tuning, conducting performance testing on applications, getting real-time traces, and gaining data insights. It helps in improving throughput and tuning infrastructure. The trace metrics and data collected provide valuable insights.
Ravi ShankarSundarasan - PeerSpot reviewer
Senior Enterprise Cloud Architect at Blue Yonder
Real-time monitoring has improved incident response and supports proactive anomaly detection
The advantages and strong points of ITRS Geneos for me personally are seamless integration with existing systems as well as upcoming modern systems. The user interface is really good. From a management point of view, these are the key aspects with respect to the user interface and seamless integration. We get very good community support for this product. ITRS Geneos has impacted my organization positively, and I would rate it 4.5 out of 5.

Quotes from Members

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Pros

"AWS X-Ray is a strong solution and has a smooth integration process."
"The solution has made it easier for us to trace the problems that we have with our requests and to monitor the timing of each step in each request we do in our endpoints."
"The error analysis capabilities of X-Ray are really good."
"The most promising feature of AWS X-Ray is that you can debug the issues through the proper logs. You can also get an analysis out of the logs for some use cases, though I have yet to try all the features of AWS X-Ray."
"The most important one is compliance. We're able to achieve our regulatory levels. We're able to achieve the security level that we need for the federal government."
"The most beneficial feature is that it shows a dashboard for performance intervals, which reveals latencies."
"AWS X-Ray shows us exactly when there are delays, helping us understand the depth of issues and what is happening point-to-point."
"AWS X-RAY identifies bottlenecks in terms of stability and performance and how long certain data lives in terms of response time and duration."
"The flexibility of the product is most valuable. It is highly customizable. If you put your mind to it and think of something you could do, there's a good possibility you can get it integrated within the console, if it's not readily available. The simplicity or ease of customization has been valuable."
"It's a very effective and productive tool, and avoids any major incidents."
"The tool is highly customizable and can be tailored to your requirements."
"The ability to build integrations to tools that are not monitored out of the box is the most valuable feature."
"The Netprobe is so lightweight compared to the agents that most monitoring tools use. It's really superior to the competition. The agent that is used by almost every competitive tool takes a lot more system resources. It's slower and it requires a greater effort and more compromises in terms of security to install on the monitored servers. With Geneos, because it lives outside the code, it is far easier and far less taxing on the monitored systems."
"The filtering in the Active Console is exceptional. Depending on the user base, some people don't want to see server-level errors, so we have filters set up in the Managed Entities view, which allow us to filter out things that certain groups don't want to see, while allowing them to see other things. It's a great real-time monitoring solution. And you can draw graphs immediately, right from the Active Console, whether they're current graphs or historical graphs."
"The great advantage of this tool is real-time monitoring."
"It allowed us to deal with incidents in real time, reducing the impact on the business by allowing them to keep trading, therefore not losing money."
 

Cons

"Like most Amazon products, the user interface, configuration, and tuning aren't the easiest. That's the biggest reason why people tend to go to products like TerraForm and Terragrunt. We use TerraForm and Terragrunt. So, for setting things up and interacting with X-Ray, it's definitely the user interface that can be better."
"If you have a small team, it's probably overkill."
"Sometimes, the collector agents are confusing to configure initially."
"A significant downside is that it is very expensive."
"The user interface is sometimes kind of confusing to understand. It's not very user-friendly."
"It should have X-Ray SDKs for different languages like Node.js, Python, or Java."
"AWS X-Ray should improve its implementation process to make it easier for developers."
"What needs to be better in AWS X-Ray is the log filtering. Predefined filters could be helpful because the power of analytics comes from how you can filter the data. I also want to see more KPIs from AWS X-Ray."
"The interface can sometimes be a little complicated."
"There is one drawback to using lightweight data collection: we lack the feature of observability based on time series, such as historical model data. This makes it difficult to view data in ITRS. ITRS needs to improve this feature."
"I would really like to see something from the Geneos side to set up automated reporting from ITRS."
"I would like to see ITRS integrate its setup editor with a SVN to check-in setup XML after major changes."
"Not a ten because when the Gateway was very overloaded it was very hard to monitor the alerts, especially for the product services."
"For the solution to stay relevant in the cloud-based monitoring environment Geneos needs more plug-ins with more features. Instead of offering clients workarounds, the solution should have a cloud-based out-of-the-box version."
"Some aspects of dashboarding are very proprietary and it makes it difficult, at times, to replicate your work easily."
"The main weakness of the product is poor historical logging and reporting."
 

Pricing and Cost Advice

"The pricing for AWS X-Ray is a six out of ten."
"The solution is a bit expensive."
"As you develop a relationship with Amazon, your pricing gets lower. You get credits for the amount of the system you use, and then if you're the government, you can get government pricing. For commercial users, there's a hump when you go from small to medium to big enterprise. Small businesses can live pretty easily off the free tier in a lot of cases, but when you go from a medium to a big enterprise, it becomes more expensive on a per-user basis. I'd like to see that curve going in a different way where pricing can be driven down while people are trying to adopt the technology."
"Pricing and licensing is based on the requirements."
"ITRS Geneos is not a cheap tool. It's a moderate price for the banking industry. The reason we are not able to add the ITRS monitoring tool for the non-banking industries, and non-finance industries, is that the pricing is too high."
"The licensing cost may seem expensive upfront. However, the service is outstanding, the tool does things that no other tools can do, and the customizability more than makes up for the cost of licensing."
"Based on feedback from colleagues and friends working in the financial sector, Geneos is relatively costly. Many companies have been switching from Geneos to Dynatrace, Sysdig, or other monitoring tools in the past two years because of the price."
"I can say it's not that cheap because the licensing is a little bit costly"
"The pricing seems reasonable. We're happy enough with it."
"When I first came in, their pricing was very high. ITRS had a high expectation of what their price should be based on perceived value. I think they have been realizing, more recently, that there are other competitors, so their pricing is a lot better. Licensing for on-premise is okay, however I feel there is quite some work to be done for cloud and containers. We're still working with them to try and work out what that pricing should look like."
"Its price is reasonable. It isn't too expensive, and it isn't too cheap, but it also depends on a company's volume and negotiation."
report
Use our free recommendation engine to learn which Application Performance Monitoring (APM) and Observability solutions are best for your needs.
915,341 professionals have used our research since 2012.
 

Top Industries

By visitors reading reviews
Financial Services Firm
11%
Comms Service Provider
10%
Computer Software Company
8%
University
8%
Financial Services Firm
47%
Outsourcing Company
10%
Construction Company
7%
Manufacturing Company
6%
 

Company Size

By reviewers
Large Enterprise
Midsize Enterprise
Small Business
By reviewers
Company SizeCount
Small Business8
Large Enterprise3
By reviewers
Company SizeCount
Small Business6
Midsize Enterprise12
Large Enterprise40
 

Questions from the Community

What is your experience regarding pricing and costs for AWS X-Ray?
While I have not compared it with GCP or Azure ( /products/microsoft-azure-reviews ), AWS generally offers cost-effective services. Some services, like Athena ( /products/odyssey-software-athena-eo...
What needs improvement with AWS X-Ray?
The challenges we faced with AWS X-Ray were that some of the AWS services we were using did not support it, which we discovered at a later stage. This was potentially a design consideration we shou...
What is your primary use case for AWS X-Ray?
I have been using AWS X-Ray for creating insights to our applications we have developed. It is used to correlate different services in AWS when a transaction happens, allowing us to see the flow of...
What is your experience regarding pricing and costs for ITRS Geneos?
I do not have the pricing information because it lies with the finance team.
What needs improvement with ITRS Geneos?
I do not see much room for improvement. Support for data cloud platforms could be great. Modern cloud platforms and data cloud platforms require more attention from the product.
What is your primary use case for ITRS Geneos?
I was using ITRS Geneos at HSBC. I have been using this product for more than two years. I have 20 years of experience working in IT with software in general. I am working with an on-premises deplo...
 

Comparisons

 

Also Known As

No data available
Geneos
 

Overview

 

Sample Customers

COMCAST, ConnectWise, skyscanner, AirAsia, cookpad, cimpress, VTEX, zowdow
ITRS Geneos is used by over 170 financial institutions, including JPMorgan, HSBC, RBS, Deutsche Bank and Goldman Sachs. Clients range from investment banks to exchanges and brokers.
Find out what your peers are saying about AWS X-Ray vs. ITRS Geneos and other solutions. Updated: September 2026.
915,341 professionals have used our research since 2012.